Delisting riskPopularity #3,733
BioVie (BIVI)
Develops bezisterim and continuous-infusion terlipressin therapies.
$1.63
After hours−0.01 (−0.31%)
At close$1.64(+0.31%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
estimated · in 47 days
EPS estimate
—
Revenue estimate
—
Fiscal quarter
Q1 FY27
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$4.60−$1.50−$1.82−$0.98−$0.77−$0.70−$0.70Pending
Estimate−$16.00−$3.20−$1.82−$0.79−$0.81−$0.73−$0.52—
Surprise+71.3%+53.1%0.0%−24.1%+4.9%+4.1%−34.6%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.00 | — | — |
| Aug 2026 | −$0.52 | −$0.70 | −34.6% |
| May 2026 | −$0.73 | −$0.70 | +4.1% |
| Feb 2026 | −$0.81 | −$0.77 | +4.9% |
| Nov 2025 | −$0.79 | −$0.98 | −24.1% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Sep 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Sep 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Jan 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Sep 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Oct 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Sep 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | $0.00 | — | — | $0 | — | — | — |
| Aug 12, 2026 | −$0.52 | −$0.70 | −34.6% | — | — | — | +22.8% |
| May 11, 2026 | −$0.73 | −$0.70 | +4.1% | — | — | — | −2.2% |
| Feb 10, 2026 | −$0.81 | −$0.77 | +4.9% | — | — | — | −3.4% |
| Nov 10, 2025 | −$0.79 | −$0.98 | −24.1% | — | — | — | −3.2% |
| Aug 15, 2025 | |||||||
| May 12, 2025 | |||||||
| Feb 11, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Sep 30, 2024 | |||||||
| May 14, 2024 | |||||||
| Feb 12, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 16, 2023 | |||||||
| May 12, 2023 | |||||||
| Feb 10, 2023 | |||||||
| Nov 4, 2022 | |||||||
| Sep 27, 2022 | |||||||
| May 11, 2022 | |||||||
| Feb 8, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 30, 2021 | |||||||
| May 10, 2021 | |||||||
| Jan 29, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 13, 2020 | |||||||
| Feb 13, 2020 | |||||||
| Nov 19, 2019 | |||||||
| Sep 27, 2019 | |||||||
| May 10, 2019 | |||||||
| Feb 12, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Oct 5, 2018 | |||||||
| May 14, 2018 | |||||||
| Feb 14, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 23, 2017 | |||||||
| May 9, 2017 | |||||||
| Feb 7, 2017 | |||||||
| Nov 16, 2016 | |||||||
| Sep 28, 2016 | |||||||
| May 23, 2016 | |||||||
| Feb 16, 2016 | |||||||
| Nov 13, 2015 | |||||||
| Sep 30, 2015 |